Dorothea Sesardic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorothea Sesardic has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Paul Stickings
Division of Bacteriology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK
3 shared publications - Peter Rigsby
Biostatistics Section, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK
3 shared publications - Philippe Thullier
Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées, 91220 Brétigny-sur-Orge, France
2 shared publications - Russell G. A. Jones
MicroPharm Ltd., Newcastle Emlyn, Carmarthenshire, UK; Department of Clinical Biochemistry, Barts and The London School of Medicine and Dentistry, London, UK
2 shared publications A. Mérens
Ecole du Val de Grâce, Paris, France
1 shared publicationC. Rasetti-Escargueil
National Institute for Biological Standards and Control, Health Protection Agency, Potters Bar, UK
1 shared publication
Latest Publications
- Open Access
- 1 November 2016
- Published by Elsevier in Biologicals
- Vol. 44 (6) , 556-566
Collaborative study for the calibration of a replacement International Standard for diphtheria toxoid for use in flocculation test
- 1 November 2016
- Published by Elsevier in Biologicals
- Vol. 44 (6) , 556-566
Open AccessCollaborative study for the calibration of a replacement International Standard for diphtheria toxoid for use in flocculation test
- 30 November 2011
- Published by Elsevier in Biologicals
- Vol. 39 (6) , 404-416
Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed
- 30 November 2011
- Published by Elsevier in Biologicals
- Vol. 39 (6) , 404-416
Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed
- Open Access
- 23 November 2011
- Published by Springer Nature in BMC Biotechnology
- Vol. 11 (1) , 113
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin
Background: Botulinum neurotoxin A (BoNT/A), mainly represented by subtype A1, is the most toxic substance known. It causes naturally-occurring food poisoning, and is among the biological agents at the highest risk of being weaponized. Several antibodies neutralizing BoNT/A by targeting its heavy chain (BoNT/A-H) have been isolated in the past. For the first time however, an IgG (4LCA) recently isolated by hybridoma technology and targeting the BoNT/A light chain (BoNT/A-L), was shown to inhibit BoNT/A endopeptidase activity and protect in vivo against BoNT/A. In the present study, a phage-displayed library was constructed from a macaque (Macaca fascicularis) hyper-immunized with BoNTA/L in order to isolate scFvs inhibiting BoNT/A endopeptidase activity for clinical use. Results: Diversity of the scFvs constituting the library was limited due to the frequent presence, within the genes intended to be part of the library, of restriction sites utilized for its construction. After screening with several rounds of increasing stringency, as is usual with phage technology, the library got overwhelmed by phagemids encoding incomplete scFvs. The screening was successfully re-performed with a single round of high stringency. In particular, one of the isolated scFvs, 2H8, bound BoNT/A1 with a 3.3 nM affinity and effectively inhibited BoNT/A1 endopeptidase activity. The sequence encoding 2H8 was 88% identical to human germline genes and its average G-score was -0.72, quantifying the high human-like quality of 2H8. Conclusions: The presence of restrictions sites within many of the sequences that were to be part of the library did not prevent the isolation of an scFv, 2H8, by an adapted panning strategy. ScFv 2H8 inhibited toxin endopeptidase activity in vitro and possessed human-like quality required for clinical development. More generally, the construction and screening of phage-displayed libraries built from hyper-immunized non-human primates is an efficient solution to isolate antibody fragments with therapeutic potential.
- 23 November 2011
- Published by Springer Nature in BMC Biotechnology
- Vol. 11 (1) , 113
Open AccessIsolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin
Background: Botulinum neurotoxin A (BoNT/A), mainly represented by subtype A1, is the most toxic substance known. It causes naturally-occurring food poisoning, and is among the biological agents at the highest risk of being weaponized. Several antibodies neutralizing BoNT/A by targeting its heavy chain (BoNT/A-H) have been isolated in the past. For the first time however, an IgG (4LCA) recently isolated by hybridoma technology and targeting the BoNT/A light chain (BoNT/A-L), was shown to inhibit BoNT/A endopeptidase activity and protect in vivo against BoNT/A. In the present study, a phage-displayed library was constructed from a macaque (Macaca fascicularis) hyper-immunized with BoNTA/L in order to isolate scFvs inhibiting BoNT/A endopeptidase activity for clinical use. Results: Diversity of the scFvs constituting the library was limited due to the frequent presence, within the genes intended to be part of the library, of restriction sites utilized for its construction. After screening with several rounds of increasing stringency, as is usual with phage technology, the library got overwhelmed by phagemids encoding incomplete scFvs. The screening was successfully re-performed with a single round of high stringency. In particular, one of the isolated scFvs, 2H8, bound BoNT/A1 with a 3.3 nM affinity and effectively inhibited BoNT/A1 endopeptidase activity. The sequence encoding 2H8 was 88% identical to human germline genes and its average G-score was -0.72, quantifying the high human-like quality of 2H8. Conclusions: The presence of restrictions sites within many of the sequences that were to be part of the library did not prevent the isolation of an scFv, 2H8, by an adapted panning strategy. ScFv 2H8 inhibited toxin endopeptidase activity in vitro and possessed human-like quality required for clinical development. More generally, the construction and screening of phage-displayed libraries built from hyper-immunized non-human primates is an efficient solution to isolate antibody fragments with therapeutic potential.
- 30 September 2010
- Published by Elsevier in Biologicals
- Vol. 38 (5) , 529-538
Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed
- 30 September 2010
- Published by Elsevier in Biologicals
- Vol. 38 (5) , 529-538
Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed
- Open Access
- 1 July 2010
- Published by Springer Nature in Drugs in R&D
- Vol. 10 (2) , 91-92
Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
- 1 July 2010
- Published by Springer Nature in Drugs in R&D
- Vol. 10 (2) , 91-92
Open AccessIs it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
- 1 January 2010
- Published by Springer Nature
- p. 705-722
Neutralization Tests